10-24-2018 03:23 PM CET - Health & Medicine
Print

Cancer Diagnostics Market Research Report| Key Players: Agilent Technologies, Alere Inc., Danaher Corporation, GE Healthcare, Hologic, Inc., Bio-Rad Laboratories, Kalila Medical

Press release from: Cancer Diagnostic
Cancer Diagnostics Market
Cancer Diagnostics Market
Recent technological advancements enabling quick and accurate diagnosis will propel global market growth. Patients are receiving treatment specifically tailored with accordance to their genetic makeup with the help of diagnosis based of next generation sequencing and liquid biopsy. Advent of such technologies in near future will support industry growth. However, prohibitive cost of diagnosis is hampering adoption rates in countries with low income levels. Risk of radiations exposure will further impede market growth over the forecast period.

Request for a sample of this research report @ www.gminsights.com/request-sample/detail/2406

Imaging application segment held largest revenue share in 2016 and the trend is expected to continue over the forecast timeframe owing to wide range of applicability of imaging devices to detect majority of cancer types. Advent of technologically advanced devices such as computed tomography and positron emission tomography devices will positively impact market growth.

These devices provide high quality imaging at lower radiation dose. The side effects associated with usage of some conventional imaging devices due to radiation exposure will hinder segment growth to some extent.

The liver-lung cancer application segment accounted for majority of market share in 2016. The segment growth is largely supported by increasing prevalence due to changing dietary habits such as increasing alcohol consumption and smoking.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

1.Agilent Technologies
2.Alere Inc.
3.Danaher Corporation
4.GE Healthcare
5.Hologic, Inc.
6.Bio-Rad Laboratories
7.Kalila Medical(Abbott Laboratories)
8.BD
9.Biocartis
10.Biocare Medical
11.bioMérieux
12.Cancer Genetics, Inc.

U.S. dominated global market in 2016, due to high research and development activities focused at developing better diagnostic methods. Presence of leading medical technology and biotechnology firms coupled with high adoption rates of technologically superior diagnostic methods will drive the U.S. market growth over the forecast timeframe.

China cancer diagnostic market should witness robust growth due to presence of large patient pool and increasing disposable income. Growing awareness pertaining to benefits of early diagnosis will propel market growth. However, being a price sensitive market, inflated cost of some advanced diagnostic tests may limit regional growth to some extent.

Make an inquiry for purchasing this report @ www.gminsights.com/inquiry-before-buying/2406

Cancer Diagnostics Market by Cancer Type
• Bladder Cancer
Breast Cancer
• Colon and Rectal Cancer
• Endometrial Cancer
• Kidney Cancer
• Leukemia
• Liver-Lung Cancer
• Melanoma
• Non-Hodgkin Lymphoma
• Pancreatic Cancer
• Prostate Cancer
• Thyroid Cancer

Cancer Diagnostics Market by End Use
• Hospitals
• Diagnostic Laboratories
• Diagnostic Imaging Centers
• Cancer Research Institutes

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.
News-ID: 1326016 • Views: 604
More releasesMore releases

You can edit or delete your press release here: